Literature DB >> 29419424

Levels of the erythropoietin-responsive hormone erythroferrone in mice and humans with chronic kidney disease.

Mark R Hanudel1, Maxime Rappaport2, Kristine Chua3, Victoria Gabayan3, Bo Qiao3, Grace Jung3, Isidro B Salusky2, Tomas Ganz3, Elizabeta Nemeth3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29419424      PMCID： PMC5865435          DOI： 10.3324/haematol.2017.181743

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   11.047


× No keyword cloud information.
  7 in total

1.  Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.

Authors:  Léon Kautz; Grace Jung; Xin Du; Victoria Gabayan; Justin Chapman; Marc Nasoff; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2015-08-14       Impact factor: 22.113

2.  Immunoassay for human serum erythroferrone.

Authors:  Tomas Ganz; Grace Jung; Arash Naeim; Yelena Ginzburg; Zahra Pakbaz; Patrick B Walter; Léon Kautz; Elizabeta Nemeth
Journal:  Blood       Date:  2017-07-24       Impact factor: 22.113

3.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

Review 4.  Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis.

Authors:  F Morceau; M Dicato; M Diederich
Journal:  Mediators Inflamm       Date:  2010-03-01       Impact factor: 4.711

5.  Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.

Authors:  Ferruh Artunc; Teut Risler
Journal:  Nephrol Dial Transplant       Date:  2007-06-07       Impact factor: 5.992

6.  Identification of erythroferrone as an erythroid regulator of iron metabolism.

Authors:  Léon Kautz; Grace Jung; Erika V Valore; Stefano Rivella; Elizabeta Nemeth; Tomas Ganz
Journal:  Nat Genet       Date:  2014-06-01       Impact factor: 38.330

7.  Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.

Authors:  Hirokazu Honda; Yasuna Kobayashi; Shoko Onuma; Keigo Shibagaki; Toshitaka Yuza; Keiichi Hirao; Toshinori Yamamoto; Naohisa Tomosugi; Takanori Shibata
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240
  7 in total
  12 in total

1.  Erythroferrone Expression in Anemic Rheumatoid Arthritis Patients: Is It Disordered Iron Trafficking or Disease Activity?

Authors:  Soha R Youssef; Esraa H Hassan; Caroline S Morad; Adel A Elazab Elged; Rasha A El-Gamal
Journal:  J Inflamm Res       Date:  2021-09-07

2.  Associations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipients.

Authors:  Blair Limm-Chan; Katherine Wesseling-Perry; Meghan H Pearl; Grace Jung; Eileen Tsai-Chambers; Patricia L Weng; Mark R Hanudel
Journal:  Pediatr Nephrol       Date:  2021-04-26       Impact factor: 3.714

3.  Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.

Authors:  Katherine M Delaney; Ronnie Guillet; Eva K Pressman; Tomas Ganz; Elizabeta Nemeth; Kimberly O O'Brien
Journal:  J Nutr       Date:  2021-07-01       Impact factor: 4.687

Review 4.  Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.

Authors:  Daniel N Srole; Tomas Ganz
Journal:  J Cell Physiol       Date:  2020-12-28       Impact factor: 6.513

5.  Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD).

Authors:  Megan L Noonan; Erica L Clinkenbeard; Pu Ni; Elizabeth A Swallow; Samantha P Tippen; Rafiou Agoro; Matthew R Allen; Kenneth E White
Journal:  Physiol Rep       Date:  2020-06

Review 6.  Established and Emerging Concepts to Treat Imbalances of Iron Homeostasis in Inflammatory Diseases.

Authors:  Verena Petzer; Igor Theurl; Günter Weiss
Journal:  Pharmaceuticals (Basel)       Date:  2018-12-11

7.  Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure.

Authors:  Paul Robach; Elena Gammella; Stefania Recalcati; Domenico Girelli; Annalisa Castagna; Matthieu Roustit; Carsten Lundby; Anne-Kristine Lundby; Pierre Bouzat; Samuel Vergès; Guillaume Séchaud; Pierluigi Banco; Mario Uhr; Catherine Cornu; Pierre Sallet; Gaetano Cairo
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

8.  Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone.

Authors:  Laura Diepeveen; Rian Roelofs; Nicolai Grebenchtchikov; Rachel van Swelm; Leon Kautz; Dorine Swinkels
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

9.  Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.

Authors:  Andreas Breenfeldt Andersen; Thomas C Bonne; Jacob Bejder; Grace Jung; Tomas Ganz; Elizabeta Nemeth; Niels Vidiendal Olsen; Jesús Rodríguez Huertas; Nikolai Baastrup Nordsborg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-06-23       Impact factor: 3.210

Review 10.  Biomarkers of iron metabolism in chronic kidney disease.

Authors:  Glogowski Tomasz; Wojtaszek Ewa; Malyszko Jolanta
Journal:  Int Urol Nephrol       Date:  2020-10-06       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.